Efficacy and safety of alvimopan use in benign urinary tract reconstruction.

Patrick J HensleyMargaret HigginsAlison RasperAli ZiadaStephen StrupClyde ColemanKathryn RufShubham Gupta

Published in: International urology and nephrology (2020)

The use of perioperative alvimopan in benign abdominal urinary tract reconstruction expedited return of bowel function and decreased length of stay compared to a matched cohort of untreated patients.

Keyphrases

urinary tract
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patients undergoing
prognostic factors
cardiac surgery